Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

Malaria Journal(2020)10.1186/s12936-020-03368-5Source: DataRank Database

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose is a research paper published in Malaria Journal (2020). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.48)OA: goldTopics (60)Linked Datasets (16)DataCite Reuse (16)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Bingbing Deng,Moustafa T. Mabrouk ORCID,Amal Seffouh,Joaquı́n Ortega ORCID,Carole A. Long ORCID

Live enrichment

PubMed:32859199 PMC:PMC7453371 OpenAlex:https://openalex.org/W3082923610

National Institutes of Health

Grant: R21AI122964

National Institutes of Health

Grant: R01AI148557

National Institutes of Health

Grant: 5R01AI148557-02

Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine

National Institutes of Health

Grant: 5R21AI122964-02

A His-tag Binding Membrane System for Generating Neutralizing Gp41 MPER antibodies

FWCI

5.48

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1186/s12936-020-03368-5

GOLDhttps://doi.org/10.1186/s12936-020-03368-5

publisherhttps://doi.org/10.1186/s12936-020-03368-5

publisherhttps://link.springer.com/content/pdf/10.1186/s12936-020-03368-5.pdf

publisherhttps://link.springer.com/article/10.1186/s12936-020-03368-5/fulltext.html

Fields of Study

Malaria Research and ControlImmunotherapy and Immune Responsesvaccines and immunoinformatics approachesMedicineChemistryBiology0301 basic medicine0303 health sciences03 medical and health sciencesAdjuvants, ImmunologicAnimalsFemaleImmunizationInjections, IntramuscularLipid ALiposomesMalaria VaccinesMalaria, FalciparumMiceRabbits

MeSH Terms

Adjuvants, ImmunologicAnimalsFemaleImmunizationInjections, IntramuscularLipid ALiposomesRabbitsMalaria, FalciparumMalaria VaccinesMice

Keywords

AntigenBiologyAntibodyBivalent (engine)VirologyAdjuvantMolecular biologyImmunologyChemistryLiposomesMalariaTransmission-blocking vaccinePfs230Pfs25ResearchRC955-962Infectious and parasitic diseasesRC109-216Injections, IntramuscularMiceLipid AAdjuvants, ImmunologicArctic medicine. Tropical medicineMalaria VaccinesAnimalsFemaleImmunizationRabbitsMalaria, Falciparum

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

10.6084/m9.figshare.12891165.v1figshare

Additional file 1 of Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

10.6084/m9.figshare.12891165figshare

Additional file 2 of Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

10.6084/m9.figshare.14559041.v1figshare

Additional file 2 of Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

10.6084/m9.figshare.14559041figshare

Additional file 1 of Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

10.6084/m9.figshare.19845689.v1figshare

Additional file 1 of Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

10.6084/m9.figshare.19845689figshare

Additional file 2 of Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

10.6084/m9.figshare.19845692.v1figshare

Additional file 2 of Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

10.6084/m9.figshare.19845692figshare

Additional file 3 of Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

10.6084/m9.figshare.19845695.v1figshare

Additional file 3 of Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25

10.6084/m9.figshare.19845695figshare

Additional file 3 of Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

10.6084/m9.figshare.14559044.v1figshare

Additional file 3 of Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

10.6084/m9.figshare.14559044figshare

Additional file 1 of Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

10.6084/m9.figshare.14559038figshare

Additional file 1 of Evaluation of two sexual-stage antigens as bivalent transmission-blocking vaccines in rodent malaria

10.6084/m9.figshare.14559038.v1figshare

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

10.6084/m9.figshare.c.5106348figshare

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

10.6084/m9.figshare.c.5106348.v1figshare

Related Papers (6)

SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination

Advanced Materials(2020)

co-cited

10.1002/adma.202005637

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

npj Vaccines(2020)

co-cited

10.1038/s41541-020-0173-x

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages

Communications Biology(2022)

co-cited

10.1038/s42003-022-03688-z

Vaccines for immune tolerance against autoimmune disease

Advanced Drug Delivery Reviews(2023)

co-cited

10.1016/j.addr.2023.115140

SARS‐CoV‐2 Protein Nanoparticle Vaccines Formed In Situ From Lyophilized Lipids

Small(2023)

co-cited

10.1002/smll.202304534

Interim safety and immunogenicity analysis of the EuCorVac‐19 COVID‐19 vaccine in a Phase 3 randomized, observer‐blind, immunobridging trial in the Philippines

N/A

0.470DataRank · unranked

Journal of Medical Virology(2024)

co-cited

10.1002/jmv.29927

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Linked Datasets (16)

Annotations (Europe PMC)

Related Papers (6)